PGNX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Fees and other income is the income earned by insurance companies other than providing insurances. Progenics Pharmaceuticals Inc's fees and other income for the three months ended in Mar. 2014 was $1.82 Mil. Its fees and other income for the trailing twelve months (TTM) ended in Mar. 2014 was $7.45 Mil.
Progenics Pharmaceuticals Inc's quarterly fees and other income increased from Sep. 2013 ($0.87 Mil) to Dec. 2013 ($2.97 Mil) but then declined from Dec. 2013 ($2.97 Mil) to Mar. 2014 ($1.82 Mil).
Progenics Pharmaceuticals Inc's annual fees and other income declined from Dec. 2011 ($84.80 Mil) to Dec. 2012 ($14.05 Mil) and declined from Dec. 2012 ($14.05 Mil) to Dec. 2013 ($7.86 Mil).
Income earned by insurance companies other than providing insurances. It includes investing income, fees and interest income.
Progenics Pharmaceuticals Inc Fees and Other Income for the trailing twelve months (TTM) ended in Mar. 2014 was 1.801 (Jun. 2013 ) + 0.867 (Sep. 2013 ) + 2.968 (Dec. 2013 ) + 1.815 (Mar. 2014 ) = $7.45 Mil.
Progenics Pharmaceuticals Inc Annual Data
Progenics Pharmaceuticals Inc Quarterly Data